Drugs and The Future
Drugs and The Future
ix
FOREWORD
What will all of this mean to future generations? Great promise, but the potential for unintended adverse consequences as well. I believe that the following ethical and procedural issues must be considered in sanctioning the development and distribution of psychotropic agents that enhance normal performance and other desirable human qualities. First, I am concerned about access to such psychotropic agents. Will they be prescribed by physicians? How will physicians decide for whom they will prescribe such psychotropic agents? How will they be paid for? If only individuals who can afford to pay for these agents can access them, are we further separating individuals by socioeconomic level? Are we in danger of creating a modern-day equivalent to a behavioural eugenics movement or a caste system? Further, will ambitious young workers escalate their use of such agents in an attempt to better compete with their peers? The current furore over the use of performance-enhancing anabolic steroids by athletes in the United States portends some of the problems we will have with steroids for the mind. Finally, what will happen to ones sense of satisfaction for a job well done if the successful performance is at least partly attributable to a pill? If increased compassion or empathy can be achieved by ingesting a psychotropic agent, will this alter our veneration for these human attributes? I do not mean to diminish the possible benets that might accrue from new psychotropic agents for enhancing normal performance and other desirable human qualities. It seems conceivable that, if an
entire population received a psychotropic agent that boosts memory function, we would not equalise individual differences but rather increase the population mean for memory function. This could be true for all of the human mental functions that psychotropic agents might enhance. This is, of course, a utopian view, but conceivable. Unfortunately, the reality is that such agents would be disproportionately available for the wealthier nations populations potentially further widening the socioeconomic gap between nations of the world. As is true with all medications, fashioning rational policies requires that we balance the risks and benets of these agents for the individual and society in general. We must also seriously consider alternatives to psychotropic agents for enhancing normal performance. Much can be achieved using educational and other behavioral approaches to enhance our mental performances. Clearly, we can also do a better job of nurturing the human qualities of empathy, compassion and spirituality by means other than psychotropic agents, probably at lower cost and with reduced likelihood of adverse side effects. Nevertheless, we should not prejudge the potential benets of psychotropic agents for purposes other than treatment of disease. Whether or not we oppose this application of psychotropic drugs based on ethical principles, they will be developed. Once developed, it will be difcult to contain their distribution and use. It is far better that we begin our public discourse now on policies to productively use these agents rather than wait until they are here.